Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
Discussion MDSCs violently emerge in pathological conditions in an attempt to limit potentially harmful immune and inflammatory responses. Mechanisms supporting their expansion and survival are deeply investigated in cancer, in the perspective to reactivate specific antitumor responses and prevent their contribution to disease evolution. These findings will likely contribute to improve the targeting of MDSCs in anticancer immunotherapies, either alone or in combination with immune checkpoint inhibitors. New evidence indicates that the expansion of myeloid cell differentiation in pathology is subject to fine-tuning, as its alterations may support either immunosuppression or autoimmunity. This pathological plasticity is supported by evidence indicating that common MDSC-associated targets may be specularly targeted in autoimmunity vs. cancer (12), and there is now hope that understanding autoimmune mechanisms might serve as a lesson for the development of new anticancer therapies. The functional plasticity and therapeutic ductility of these cells (Figure 2) suggest that while MDSC inhibition might succeed as anticancer treatment, their induction is expected to provide therapeutic benefit in autoimmune diseases. FIGURE 2 Figure 2. Schematic role of MDSCs in pathology. Immunological stress induces the expansion of MDSCs that play different roles depending on distinct pathological and microenvironmental contexts. MDSCs are characterized by the strong ability to suppress ...
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Jinsoo Lee, Seong-Jin Choi, Ji-Seong Jeong, Sang Yun Kim, Sang-Hyub Lee, Mi Jin Yang, Seung-Jin Lee, Young-Jun Shin, Kyuhong Lee, Eun Ju Jeong, Sang-Yoon Nam, Wook-Joon Yu
Publication date: Available online 30 September 2020Source: Journal of Hazardous MaterialsAuthor(s): Anthony Beauvois, Delphine Vantelon, Jacques Jestin, Martine Bouhnik-Le Coz, Charlotte Catrouillet, Valérie Briois, Thomas Bizien, Mélanie Davranche
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Publication date: Available online 10 October 2020Source: Meta GeneAuthor(s): Mansour Zamanpoor, Hamid Ghaedi, Mir Davood Omrani
Authors: Mosquera J, Pedreañez A Abstract Increasing evidence supports a central role of the immune system in acute post streptococcal glomerulonephritis (APSGN), but the current view of how streptococcal biology affects immunity, and vice versa, remains to be clarified. Renal glomerular immune complex deposition is critical in the initiation of APSGN; however, mechanisms previous to immune complex formation could modulate the initiation and the progression of the disease. Initial and late renal events involved in the nephritis can also be related to host factors and streptococcal factors. In this review we ...
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Publication date: Available online 10 October 2020Source: European UrologyAuthor(s): Stanley Weng, Renzo G. DiNatale, Andrew Silagy, Roy Mano, Kyrollis Attalla, Mahyar Kashani, Kate Weiss, Nicole E. Benfante, Andrew G. Winer, Jonathan A. Coleman, Victor E. Reuter, Paul Russo, Ed Reznik, Satish K. Tickoo, A. Ari Hakimi
Publication date: Available online 10 October 2020Source: European Journal of Surgical OncologyAuthor(s): Tetsutaro Miyoshi, Satoshi Yamaguchi, Hiroshi Fujimoto, Shigeru Yoshioka, Masayuki Shiobara, Kazuo Wakatsuki, Kosuke Suda, Kotaro Miyazawa, Toshiaki Aida, Yoshihiro Watanabe, Masayuki Ohtsuka
More News: Allergy | Allergy & Immunology | Alopecia | Alopecia Areata | Antidoxidants | Arthritis | Aspirin | Autoimmune Disease | Biology | Bladder Cancer | Bone Graft | Brain | Breast Cancer | Breast Carcinoma | Calcium | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Cancer Therapy | Carcinoma | Chemotherapy | Cialis | Clinical Trials | Colon Cancer | Colorectal Cancer | Crohn's Disease | Cytology | Diabetes | Diabetes Type 1 | Disability | Emergency Medicine | Endocrinology | Environmental Health | Epithelial Cancer | Esophagus Cancer | Fortamet | Funding | Gastroenterology | Genetics | Glomeruli | Head and Neck Cancer | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | HNSCC | Immunotherapy | Infectious Diseases | Inflammatory Bowel Disease | Insulin | Italy Health | Kidney Cancer | Kidney Transplant | Kidney Transplantation | Lessons | Liver | Liver Cancer | Liver Transplant | Lung Cancer | Lung Transplant | Lupus | Lymphoma | Melanoma | Men | Metformin | Mitochondria | Mitochondrial Disease | Multiple Sclerosis | Myasthenia Gravis | Myeloma | Nephritis | Neurology | Niacin | Non-Small Cell Lung Cancer | Noonan Syndrome | Nutrition | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Parenteral Nutrition | Pathology | Pharyngeal Cancer | Pregnancy | Pregnancy and Breast Cancer | Primary CNS Lymphoma | Psoriasis | Renal Cell Carcinoma | Rheumatoid Arthritis | Rheumatology | Skin | Skin Cancer | Skin Graft | Spinal Cord Injury | Squamous Cell Carcinoma | Staphylococcus Aureus | Stem Cell Therapy | Stem Cells | Study | Thrombocytopenia | Transplants | Tuberculosis | Ulcerative Colitis | Urology & Nephrology | Viagra | Women | Yervoy